Monopar Therapeutics (MNPR) Interest Coverage Ratio (2017 - 2025)
Monopar Therapeutics (MNPR) reported Interest Coverage Ratio of 36.94 for Q3 2025, down 41.73% sequentially from 26.06 in Q2 2025.
Monopar Therapeutics (MNPR) Interest Coverage Ratio (2017 - 2025) Analysis & Trends
Monopar Therapeutics (MNPR) has 7 years of Interest Coverage Ratio data on file, last reported at 36.94 in Q3 2025.
- For the quarter ending Q3 2025, Interest Coverage Ratio changed N/A year-over-year to 36.94; the trailing twelve-month figure through Sep 2025 stood at 109.42 (changed N/A YoY), and the FY2025 full-year result was 0.38, up 187.73% from the prior year.
- Interest Coverage Ratio eased to 36.94 in Q3 2025, from 26.06 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 0.26 in Q4 2022 to a low of 805454.25 in Q1 2025.
- A 3-year average of 100847.0 and a median of 34.77 in 2022 frame the typical range for Interest Coverage Ratio.
- Across the five-year window, Interest Coverage Ratio increased 19.81% in 2021 and advanced 24.82% in 2022, its largest moves.
- Tracing MNPR's Interest Coverage Ratio over 3 years: stood at 0.35 in 2021, then rose by 24.82% to 0.26 in 2022, then sank by 14048.61% to 36.94 in 2025.
- Business Quant data shows MNPR's Interest Coverage Ratio at 36.94 in Q3 2025, 26.06 in Q2 2025, and 805454.25 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -157.58 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 7.60 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -0.38 |
| 10 | Monopar Therapeutics | 800.03 Mn | 738.20 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -36.94 |
| Jun 30, 2025 | -26.06 |
| Mar 31, 2025 | -805,454.25 |
| Dec 31, 2022 | -0.26 |
| Sep 30, 2022 | -709.09 |
| Jun 30, 2022 | -32.60 |
| Mar 31, 2022 | -516.43 |
| Dec 31, 2021 | -0.35 |
| Dec 31, 2020 | -0.43 |
| Dec 31, 2019 | -0.48 |
| Sep 30, 2019 | -100.47 |
| Jun 30, 2019 | -61.66 |
| Mar 31, 2019 | -62.06 |
| Dec 31, 2018 | -0.55 |
| Sep 30, 2018 | -88.31 |
| Jun 30, 2018 | -44.16 |
| Mar 31, 2018 | -39.57 |
| Dec 31, 2017 | -0.74 |